The HillCenter
← All coverage gaps
2026-10-25 01:32
Nationwide recall on these compound GLP-1 drugs
100%
3 outlets · Left 0 · Center 3 · Right 0
Who got there first
each line: one outlet's first article — above the track left · below right · across center
First reported by Newsweek (Center); 3 outlets over 7h.
Newsweek · +7h NewsNation · +7h The Hill
What each side is saying
- The HillCenter
The compounded GLP-1s are not FDA-approved nor name-brand.
Read at thehill.com → - NewsNationCenter
The compounded GLP-1s are not FDA-approved nor name-brand.
Read at newsnationnow.com → - NewsweekCenter
GLP-1 receptor agonists have been found to potentially reduce the risk of certain patients requiring major kidney treatment.
Read at newsweek.com →
Each blurb is the outlet's own feed summary, quoted unedited. Nothing here is generated.
3 articles, newest first · filter by side
Every headline that clustered into this story, newest first. Links go straight to the publisher - no article text is stored here, and the one image is an unmodified copy of the publisher's own thumbnail.